Partners South Estate Planning Teams Up With Omega Capital Street

20:00 EDT 5 Aug 2015 | Globe Newswire

FT. LAUDERDALE, Fla., Aug. 06, 2015 (GLOBE NEWSWIRE) -- Partners South Estate Planning, Inc. of Ft. Lauderdale, FL and Omega Commercial Finance Corporation (OCFN) of Miami Beach, FL have joined forces to bring insurance policy purchasers who are approved for premium finance funding, the Insurance Policy Capital Market program, a robust insurance investment vehicle with risk-adjusted returns and protected annual dividend income.

The joint venture will be fully owned by Partners South and Omega Capital Street, a wholly owned subsidiary of Omega commercial Finance Corporation. “This new venture and product offering gives our clients another solid investment opportunity to build their financial future,” said Dr. Timothy Fussell, Founding Partner and Chief Executive Officer of Partners South. “Through this program, they have direct-funding protection of their investment and the incoming cash flow exceeds any associated outlay.” 

The Insurance Policy Capital Market program includes a special series of preferred stock that enables the incoming dividend payment to be greater than any outgoing interest payment through the creation of a Series 007 Convertible Redeemable Preferred Fund. “We are confident this new program will new provide revenue streams and sustainable long-term growth for clients who choose this financial strategy and structure,” said Eran Danino, CEO of Omega Capital Street LLC. “Incorporating a Preferred Series 007 conversion feature into the program is a compelling factor in this offering,” he added.

For more information about this program, or Partners South/Omega Capital, visit 

About Omega Commercial Finance Corporation – Omega commercial Finance Corporation is a publicly traded financial services holding company, which trades on the OTC Market under ticker (OCFN). Principal companies operate in the commercial real estate, finance, asset-backed lending and advisory services, real estate sales and brokerage, and capital markets sector. As a holding company, OCFN collectively along with its subsidiaries’ management teams has a combined 150 years of experience and knowledge across respective business lines. Key umbrella companies are: Omega Capital Street, Omega Asset Backed Fund, Omega Factoring, Omega Venture Capital, and Veriteck Holdings Inc., which includes the nationally-growing SRG Real Estate Company and L&W Title and Legal Services, Search Healthcare Real Estate Funds, and AmericaVest Mortgage Trust, Inc.

About Partners South Estate Planning Inc. -
Partners South Estate Planning is one of the country’s premier firms specializing in Asset and Wealth protection. Partners South only works with guaranteed products and qualified plans, IRAs, SEP Plans, ROTH Plans and 401k. Partners South now has locations in Fort Lauderdale, Tampa, Orlando, Atlanta, Fountain Hills, Raleigh, San Diego, Corona, Los Angeles, Dickinson, and Watford City.

About Timothy Fussell, Ph.D - A published author with Fox Business News and invited contributor to CNN Money and Fortune Magazine, Dr. Fussell is also a Continuing Professional Education Instructor for Certified Public Accountants (CPAs), conducting nationwide training on retirement and strategic business planning using Life and Annuity products. He has created boot camps and a learning campus where new agents can learn the intricacies of finance; arming them with the knowledge and practical experience they need to better protect and serve their clients and build a thriving, sustainable business.


Contact:  Liza Corbett
Phone:  386.246.7700

Primary Logo


More From BioPortfolio on "Partners South Estate Planning Teams Up With Omega Capital Street"

Quick Search


Relevant Topics

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...